Table of Content

1 INTRODUCTION 36
1.1 STUDY OBJECTIVES 36
1.2 MARKET DEFINITION 36
1.3 MARKET SCOPE 37
1.3.1 MARKETS COVERED 37
1.3.2 INCLUSIONS & EXCLUSIONS 38
1.3.3 YEARS CONSIDERED 38
1.3.4 CURRENCY CONSIDERED 39
1.4 STAKEHOLDERS 39
1.5 SUMMARY OF CHANGES 40
2 RESEARCH METHODOLOGY 41
2.1 RESEARCH DATA 41
2.1.1 SECONDARY DATA 42
2.1.1.1 Key data from secondary sources 43
2.1.2 PRIMARY DATA 43
2.1.2.1 Key industry insights 45
2.2 MARKET SIZE ESTIMATION 46
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 51
2.4 MARKET SHARE ESTIMATION 53
2.5 STUDY ASSUMPTIONS 53
2.6 LIMITATIONS 53
2.6.1 METHODOLOGY-RELATED LIMITATIONS 53
2.6.2 SCOPE-RELATED LIMITATIONS 53
2.7 RISK ASSESSMENT 54
3 EXECUTIVE SUMMARY 55
4 PREMIUM INSIGHTS 59
4.1 LIFE SCIENCE ANALYTICS MARKET OVERVIEW 59
4.2 LIFE SCIENCE ANALYTICS MARKET, BY REGION 60
4.3 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY END USER & REGION 60
4.4 LIFE SCIENCE ANALYTICS MARKET: GEOGRAPHIC SNAPSHOT 61
4.5 LIFE SCIENCE ANALYTICS MARKET: DEVELOPED MARKETS VS. EMERGING ECONOMIES 61
?
5 MARKET OVERVIEW 62
5.1 INTRODUCTION 62
5.2 MARKET DYNAMICS 62
5.2.1 DRIVERS 63
5.2.1.1 Rising pressure to curb healthcare spending 63
5.2.1.2 Need for improved data standardization 63
5.2.1.3 Technological advancements in analytical solutions 64
5.2.1.4 Heterogeneity and complexity of big data in life sciences 65
5.2.1.5 Growing adoption of analytical solutions in clinical trials 65
5.2.1.6 Increasing R&D expenditure in pharmaceutical &
biotechnology companies 66
5.2.2 RESTRAINTS 67
5.2.2.1 High implementation costs of advanced analytical solutions 67
5.2.2.2 Data privacy concerns 67
5.2.3 OPPORTUNITIES 69
5.2.3.1 Growing focus on value-based care 69
5.2.3.2 Use of analytics in precision & personalized medicine 69
5.2.3.3 Big data analytics for R&D productivity 70
5.2.3.4 Growing adoption of cloud-based analytics 71
5.2.4 CHALLENGES 71
5.2.4.1 Issues associated with data integration 71
5.2.4.2 Shortage of skilled personnel 72
5.2.4.3 Reluctance to adopt life science analytics solutions in
emerging countries 72
5.3 INDUSTRY TRENDS 73
5.3.1 GROWING ADOPTION OF ANALYTICS IN COMMERCIAL OPERATIONS 73
5.3.2 LEVERAGING DATA & ANALYTICS TO ACCELERATE DRUG
DISCOVERY & DEVELOPMENT 74
5.3.3 FOCUS ON REAL-TIME DATA ANALYTICS 74
5.4 TECHNOLOGY ANALYSIS 75
5.4.1 KEY TECHNOLOGIES 75
5.4.1.1 Artificial intelligence and machine learning 75
5.4.1.2 Big data analytics 75
5.4.1.3 Quantum computing 76
5.4.2 COMPLEMENTARY TECHNOLOGIES 76
5.4.2.1 Bioinformatics tools 76
5.4.2.2 Internet of things 76
5.4.3 ADJACENT TECHNOLOGIES 77
5.4.3.1 Blockchain 77
5.5 ECOSYSTEM ANALYSIS 77
5.6 VALUE CHAIN ANALYSIS 79
?
5.7 PORTER’S FIVE FORCES ANALYSIS 81
5.7.1 THREAT OF NEW ENTRANTS 82
5.7.2 THREAT OF SUBSTITUTES 82
5.7.3 BARGAINING POWER OF SUPPLIERS 82
5.7.4 BARGAINING POWER OF BUYERS 82
5.7.5 INTENSITY OF COMPETITIVE RIVALRY 83
5.8 KEY STAKEHOLDERS AND BUYING CRITERIA 83
5.8.1 KEY STAKEHOLDERS IN BUYING PROCESS 83
5.8.2 BUYING CRITERIA 84
5.9 CASE STUDY ANALYSIS 85
5.9.1 NOVARTIS USES MULTI-CLOUD DATA ANALYTICS PLATFORM TO OPTIMIZE OPERATIONS AND ACCELERATE INNOVATION 85
5.9.2 SAS VISUAL ANALYTICS HELPS MAXIMIZE PROFITABILITY THROUGH PRESCRIPTIVE ANALYTICS & DATA VISUALIZATION 86
5.9.3 STREAMLINING REGULATORY MONITORING AND IMPACT ASSESSMENTS: GEDEON RICHTER’S PARTNERSHIP WITH CLARIVATE 87
5.10 REGULATORY LANDSCAPE 88
5.10.1 REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 88
5.10.2 NORTH AMERICA 90
5.10.3 EUROPE 91
5.10.4 ASIA PACIFIC 91
5.10.5 MIDDLE EAST & AFRICA 92
5.10.6 LATIN AMERICA 92
5.11 PRICING ANALYSIS 93
5.11.1 AVERAGE SELLING PRICE OF KEY PLAYERS, BY APPLICATION 94
5.11.2 AVERAGE SELLING PRICE, BY REGION 94
5.12 KEY CONFERENCES AND EVENTS, 2024–2025 95
5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 96
5.14 PATENT ANALYSIS 96
5.14.1 PATENT PUBLICATION TRENDS 96
5.14.2 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES 97
5.14.3 MAJOR PATENTS 98
5.15 END-USER ANALYSIS 99
5.15.1 UNMET NEEDS 99
5.15.2 END-USER EXPECTATIONS 101
5.16 LIFE SCIENCE ANALYTICS BUSINESS MODELS 102
5.16.1 SUBSCRIPTION-BASED MODEL 102
5.16.2 SAAS MODEL 102
5.16.3 PAY-PER-USE/USAGE-BASED MODEL 102
5.16.4 ENTERPRISE LICENSING 102
5.16.5 FREEMIUM MODEL 102
5.16.6 ENTERPRISE LICENSING 102
5.16.7 CONCURRENT LICENSING 103
5.16.8 CONSULTING SERVICES MODEL 103
5.16.9 PARTNERSHIP/REVENUE-SHARING MODEL 103
5.16.10 HYBRID MODELS 103
5.17 INVESTMENT & FUNDING SCENARIO 103
5.18 IMPACT OF AI/GENERATIVE AI ON LIFE SCIENCE ANALYTICS MARKET 106
5.18.1 TOP USE CASES & MARKET POTENTIAL 106
5.18.1.1 Key use cases 107
5.18.2 CASE STUDIES OF AI/GENERATIVE AI IMPLEMENTATION 109
5.18.2.1 Case Study 1: Knowledge Mining for a Global
Biopharmaceutical Company 109
5.18.2.2 Healthcare analytics market 110
5.18.3 USER READINESS AND IMPACT ASSESSMENT 111
5.18.3.1 User readiness 111
5.18.3.1.1 Pharmaceutical & biotechnology companies 111
5.18.3.1.2 Medical device companies 111
5.18.3.1.3 Research centers 111
5.18.3.1.4 Outsourced life science organizations 111
5.18.3.2 Impact assessment 112
5.18.3.2.1 User A: Pharmaceutical & biotechnology companies 112
5.18.3.2.1.1 Implementation 112
5.18.3.2.1.2 Impact 112
5.18.3.2.2 User B: Medical device companies 113
5.18.3.2.2.1 Implementation 113
5.18.3.2.2.2 Impact 113
5.18.3.2.3 User C: Research institutes 114
5.18.3.2.3.1 Implementation 114
5.18.3.2.3.2 Impact 114
5.18.3.2.4 User D: Outsourced life science organizations 115
5.18.3.2.4.1 Implementation 115
5.18.3.2.4.2 Impact 115
6 LIFE SCIENCE ANALYTICS MARKET, BY TYPE 116
6.1 INTRODUCTION 117
6.2 DESCRIPTIVE ANALYTICS 117
6.2.1 ADVANCED VISUAL DATA EXPLORATION AND SUPPORT FOR
INNOVATION TO DRIVE DEMAND 117
6.3 PREDICTIVE ANALYTICS 119
6.3.1 SIMULATION DEVELOPMENT FOR PREDICTING FUTURE TRENDS TO
PROPEL MARKET GROWTH 119
6.4 PRESCRIPTIVE ANALYTICS 120
6.4.1 REAL-TIME ANALYSIS FOR IMPROVED DECISION-MAKING TO
SUPPORT MARKET GROWTH 120
7 LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT 122
7.1 INTRODUCTION 123
7.2 SERVICES 123
7.2.1 MANAGED SERVICES 125
7.2.1.1 Analytical services 126
7.2.1.1.1 Focus on expediting approvals and product launches to drive growth 126
7.2.1.2 Consulting services 127
7.2.1.2.1 Support for R&D, process development, and other workflow processes to drive market 127
7.2.2 PROFESSIONAL SERVICES 128
7.2.2.1 Training & implementation 130
7.2.2.1.1 Stringent regulations, increasing competition, and need for skill development to propel demand 130
7.2.2.2 Maintenance & support services 131
7.2.2.2.1 Rising complexity of analytical technologies and expanding research needs to support market growth 131
7.2.2.3 Other professional services 132
7.3 SOFTWARE 133
7.3.1 ON-PREMISE SOLUTIONS 134
7.3.1.1 Provision of multivendor architecture and security benefits to
drive market 134
7.3.2 CLOUD-BASED SOLUTIONS 135
7.3.2.1 Real-time analysis and elimination of purchasing costs for software & hardware to drive adoption 135
7.3.3 SAAS-BASED SOLUTIONS 137
7.3.3.1 Increasing adoption of digital solutions and advantages of cloud-based models to drive growth 137
8 LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION 138
8.1 INTRODUCTION 139
8.2 RESEARCH & DEVELOPMENT 139
8.2.1 CLINICAL TRIALS 142
8.2.1.1 Life science analytics market for clinical trials, by type 143
8.2.1.1.1 Laboratory services 144
8.2.1.1.1.1 Better accuracy, efficiency, and data interpretation to support demand for lab services 144
8.2.1.1.2 Patient recruitment services 145
8.2.1.1.2.1 Need for better candidate identification and enrollment forecasting to propel market growth 145
8.2.1.1.3 Site identification services 146
8.2.1.1.3.1 Benefits in locating ideal trial sites and interpreting data to support adoption 146
8.2.1.1.4 Other clinical trial services 147
?
8.2.1.2 Life science analytics market for clinical trials, by phase 148
8.2.1.2.1 PHASE I 148
8.2.1.2.1.1 Strong pipeline of pharmaceutical companies to propel market growth 148
8.2.1.2.2 PHASE II 149
8.2.1.2.2.1 Extended duration of phase II studies to create growth opportunities for CROs 149
8.2.1.2.3 PHASE III 150
8.2.1.2.3.1 Rising trial expenditure to drive demand for cost-effective clinical research services 150
8.2.2 PRECLINICAL & DRUG DISCOVERY 151
8.2.2.1 Ability to assist researchers in process innovation and decision support to drive adoption 151
8.3 COMMERCIAL ANALYTICS 153
8.3.1 SALES & MARKETING SUPPORT 155
8.3.1.1 Rising analysis of digital marketing effectiveness to drive adoption 155
8.3.2 MARKET ACCESS 156
8.3.2.1 Focus on strategic pricing, reimbursement, and policy changes to support market growth 156
8.3.3 RWE & VALUE EVIDENCE 157
8.3.3.1 Increased data integration, partnerships, and technological to propel use of RWE 157
8.3.4 ENGAGEMENT SERVICES 158
8.3.4.1 Need for better patient engagement, digital advancements, and AI integration to propel market 158
8.4 REGULATORY COMPLIANCE 159
8.4.1 STRINGENT REQUIREMENTS FOR COMPLIANCE ADHERENCE
TO DRIVE ADOPTION 159
8.5 MANUFACTURING & SUPPLY CHAIN OPTIMIZATION 161
8.5.1 RISING NEED FOR REDUCING LOGISTICS COSTS TO
SUPPORT MARKET GROWTH 161
8.6 SAFETY 163
8.6.1 PHARMACOVIGILANCE 164
8.6.1.1 Monitoring of drug trials and medication programs to fuel
market uptake 164
8.6.2 MEDICAL DEVICE SAFETY 165
8.6.2.1 Stringent safety standards, rigorous risk assessments, and robust quality control to drive demand 165
8.6.3 DIAGNOSTIC VIGILANCE 166
8.6.3.1 Continuous monitoring, integration of diverse data sources, and ongoing education to enhance accuracy and thoroughness 166
?
9 LIFE SCIENCE ANALYTICS MARKET, BY END USER 168
9.1 INTRODUCTION 169
9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 169
9.2.1 RISING NEED FOR INNOVATIVE THERAPIES TO DRIVE ANALYTICS USAGE IN PRODUCT DEVELOPMENT 169
9.3 MEDICAL DEVICE COMPANIES 171
9.3.1 ADOPTION OF DATA ANALYTICS FOR DEVICE COMMERCIALIZATION
TO DRIVE MARKET 171
9.4 RESEARCH CENTERS 172
9.4.1 NEED FOR ANALYZING LARGE VOLUMES OF DATA TO SUPPORT
MARKET GROWTH 172
9.5 OUTSOURCED LIFE SCIENCE ORGANIZATIONS 173
9.5.1 RISING R&D OUTSOURCING BY LIFE SCIENCE COMPANIES TO DRIVE MARKET 173
10 LIFE SCIENCE ANALYTICS MARKET, BY REGION 174
10.1 INTRODUCTION 175
10.2 NORTH AMERICA 175
10.2.1 NORTH AMERICA: MACROECONOMIC OUTLOOK 176
10.2.2 US 182
10.2.2.1 Established economy and increasing R&D expenditure to drive adoption of analytical solutions 182
10.2.3 CANADA 187
10.2.3.1 Rising need for data standardization in life sciences to fuel uptake 187
10.3 EUROPE 192
10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 192
10.3.2 GERMANY 197
10.3.2.1 Growing R&D investments by pharmaceutical & biotechnology companies to drive market 197
10.3.3 FRANCE 202
10.3.3.1 Growing government support for adoption of AI & big data analytics to drive market 202
10.3.4 UK 207
10.3.4.1 Rising clinical trial activity to drive uptake of life science
analytics solutions 207
10.3.5 ITALY 212
10.3.5.1 Growing number of drug approvals to drive uptake of
analytics solutions 212
10.3.6 SPAIN 216
10.3.6.1 Surging government investments focusing on personalized medicine to drive growth 216
10.3.7 REST OF EUROPE 221
?
10.4 ASIA PACIFIC 225
10.4.1 ASIA PACIFIC: MACROECONOMIC OUTLOOK 226
10.4.2 JAPAN 232
10.4.2.1 Growing government support for clinical R&D activities to
drive adoption 232
10.4.3 CHINA 237
10.4.3.1 Growth in life science industry to support adoption of solutions 237
10.4.4 INDIA 242
10.4.4.1 Rising R&D expenditure and drug development to support
market growth 242
10.4.5 REST OF ASIA PACIFIC 247
10.5 LATIN AMERICA 252
10.5.1 LATIN AMERICA: MACROECONOMIC OUTLOOK 252
10.5.2 BRAZIL 257
10.5.2.1 Brazil to dominate life science analytics market in Latin America 257
10.5.3 MEXICO 262
10.5.3.1 Growing prominence of startups and rising R&D activity to
propel market 262
10.5.4 REST OF LATIN AMERICA 267
10.6 MIDDLE EAST & AFRICA 272
10.6.1 MIDDLE EAST & AFRICA: MACROECONOMIC OUTLOOK 272
10.6.2 GCC COUNTRIES 278
10.6.2.1 Rising investments, advancements, and developing healthcare infrastructure to drive market 278
10.6.3 REST OF MIDDLE EAST & AFRICA 283
11 COMPETITIVE LANDSCAPE 288
11.1 OVERVIEW 288
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 288
11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN LIFE SCIENCE ANALYTICS MARKET 289
11.3 REVENUE ANALYSIS 290
11.4 MARKET SHARE ANALYSIS 291
11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 292
11.5.1 STARS 293
11.5.2 EMERGING LEADERS 293
11.5.3 PERVASIVE PLAYERS 293
11.5.4 PARTICIPANTS 293
11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 295
11.5.5.1 Company footprint 295
11.5.5.2 Type footprint 296
11.5.5.3 Application footprint 297
11.5.5.4 Component footprint 298
11.5.5.5 End-user footprint 299
11.5.5.6 Region footprint 300
11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 301
11.6.1 PROGRESSIVE COMPANIES 301
11.6.2 RESPONSIVE COMPANIES 301
11.6.3 DYNAMIC COMPANIES 301
11.6.4 STARTING BLOCKS 301
11.6.5 COMPETITIVE BENCHMARKING 303
11.7 BRAND/SOFTWARE COMPARATIVE ANALYSIS 305
11.8 VALUATION & FINANCIAL METRICS 306
11.9 COMPETITIVE SCENARIO 307
11.9.1 PRODUCT LAUNCHES & APPROVALS 307
11.9.2 DEALS 308
12 COMPANY PROFILES 309
12.1 KEY PLAYERS 309
12.1.1 ORACLE 309
12.1.1.1 Business overview 309
12.1.1.2 Products & services offered 310
12.1.1.3 Recent developments 312
12.1.1.3.1 Deals 312
12.1.1.4 MnM view 312
12.1.1.4.1 Key strengths 312
12.1.1.4.2 Strategic choices 313
12.1.1.4.3 Weaknesses & competitive threats 313
12.1.2 MERATIVE 314
12.1.2.1 Business overview 314
12.1.2.2 Products & services offered 314
12.1.2.2.1 Deals 315
12.1.2.3 MnM view 315
12.1.2.3.1 Right to win 315
12.1.2.3.2 Strategic choices 315
12.1.2.3.3 Weaknesses & competitive threats 315
12.1.3 SAS INSTITUTE INC. 316
12.1.3.1 Business overview 316
12.1.3.2 Products & services offered 316
12.1.3.3 Recent developments 317
12.1.3.3.1 Product launches & approvals 317
12.1.3.3.2 Deals 317
12.1.3.4 MnM view 318
12.1.3.4.1 Right to win 318
12.1.3.4.2 Strategic choices 318
12.1.3.4.3 Weaknesses & competitive threats 318
12.1.4 ACCENTURE 319
12.1.4.1 Business overview 319
12.1.4.2 Products offered 321
12.1.4.3 Recent developments 321
12.1.4.3.1 Deals 321
12.1.4.4 MnM view 322
12.1.4.4.1 Right to win 322
12.1.4.4.2 Strategic choices 322
12.1.4.4.3 Weaknesses & competitive threats 322
12.1.5 IQVIA INC. 323
12.1.5.1 Business overview 323
12.1.5.2 Products & services offered 324
12.1.5.3 Recent developments 326
12.1.5.3.1 Product launches & approvals 326
12.1.5.3.2 Deals 326
12.1.5.3.3 Other developments 327
12.1.5.4 MnM view 327
12.1.5.4.1 Right to win 327
12.1.5.4.2 Strategic choices 327
12.1.5.4.3 Weaknesses & competitive threats 328
12.1.6 COGNIZANT 329
12.1.6.1 Business overview 329
12.1.6.2 Products & services offered 330
12.1.6.3 Recent developments 332
12.1.6.3.1 Product launches & approvals 332
12.1.6.3.2 Deals 332
12.1.7 WIPRO 333
12.1.7.1 Business overview 333
12.1.7.2 Products & services offered 334
12.1.7.3 Recent developments 336
12.1.7.3.1 Deals 336
12.1.8 VERADIGM LLC 337
12.1.8.1 Business overview 337
12.1.8.2 Products & services offered 338
12.1.8.3 Recent developments 339
12.1.8.3.1 Deals 339
12.1.9 OPTUM, INC. 340
12.1.9.1 Business overview 340
12.1.9.2 Products & services offered 341
12.1.9.3 Recent developments 341
12.1.9.3.1 Deals 341
?
12.1.10 MICROSOFT 342
12.1.10.1 Business overview 342
12.1.10.2 Products & services offered 343
12.1.10.3 Recent developments 344
12.1.10.3.1 Product & service launches & enhancements 344
12.1.10.3.2 Deals 344
12.1.11 MAXISIT 345
12.1.11.1 Business overview 345
12.1.11.2 Products & services offered 345
12.1.11.3 Recent developments 346
12.1.11.3.1 Product launches 346
12.1.11.3.2 Deals 346
12.1.12 EXLSERVICE HOLDINGS, INC. 347
12.1.12.1 Business overview 347
12.1.12.2 Products & services offered 348
12.1.12.3 Recent developments 349
12.1.12.3.1 Product launches 349
12.1.12.3.2 Deals 349
12.1.13 INOVALON 350
12.1.13.1 Business overview 350
12.1.13.2 Products & services offered 351
12.1.13.3 Recent developments 352
12.1.13.3.1 Product launches 352
12.1.13.3.2 Deals 352
12.1.14 CITIUSTECH INC. 353
12.1.14.1 Business overview 353
12.1.14.2 Products & services offered 353
12.1.14.3 Recent developments 354
12.1.14.3.1 Product launches 354
12.1.14.3.2 Deals 354
12.1.14.3.3 Expansions 355
12.1.15 SAAMA 356
12.1.15.1 Business overview 356
12.1.15.2 Products & services offered 356
12.1.15.3 Recent developments 357
12.1.15.3.1 Deals 357
12.1.16 AXTRIA 359
12.1.16.1 Business overview 359
12.1.16.2 Products & services offered 359
12.1.16.3 Recent developments 360
12.1.16.3.1 Product launches 360
12.1.16.3.2 Deals 360
12.1.16.3.3 Expansions 360
12.1.17 CLARIVATE 361
12.1.17.1 Business overview 361
12.1.17.2 Products & services offered 363
12.1.17.3 Recent developments 364
12.1.17.3.1 Product enhancements 364
12.1.17.3.2 Deals 364
12.1.18 THOUGHTSPHERE 365
12.1.18.1 Business overview 365
12.1.18.2 Products & services offered 366
12.1.18.3 Recent developments 366
12.1.18.3.1 Deals 366
12.1.19 THOUGHTSPOT INC. 367
12.1.19.1 Business overview 367
12.1.19.2 Products & services offered 367
12.1.19.3 Recent developments 368
12.1.19.3.1 Deals 368
12.1.19.3.2 Expansions 368
12.1.20 SALESFORCE, INC. 369
12.1.20.1 Business overview 369
12.1.20.2 Products & services offered 370
12.1.20.3 Recent developments 371
12.1.20.3.1 Deals 371
12.2 OTHER PLAYERS 372
12.2.1 GOOGLE LLC 372
12.2.2 AMAZON WEB SERVICES, INC. 373
12.2.3 VEEVA SYSTEMS 374
12.2.4 ELSEVIER 375
12.2.5 KOMODO HEALTH, INC. 376
13 APPENDIX 377
13.1 DISCUSSION GUIDE 377
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 382
13.3 CUSTOMIZATION OPTIONS 384
13.4 RELATED REPORTS 384
13.5 AUTHOR DETAILS 385



List of Figures

FIGURE 1 RESEARCH DESIGN 41
FIGURE 2 PRIMARY SOURCES 44
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE):
BY COMPANY TYPE, DESIGNATION, AND REGION 45
FIGURE 4 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 46
FIGURE 5 LIFE SCIENCE ANALYTICS MARKET: REVENUE SHARE ANALYSIS ILLUSTRATION 47
FIGURE 6 BOTTOM-UP APPROACH: END-USER SPENDING ON LIFE SCIENCE ANALYTICS 48
FIGURE 7 LIFE SCIENCE ANALYTICS MARKET: CAGR PROJECTION FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2024–2029) 49
FIGURE 8 CAGR PROJECTION: SUPPLY-SIDE ANALYSIS 50
FIGURE 9 TOP-DOWN APPROACH 50
FIGURE 10 DATA TRIANGULATION METHODOLOGY 52
FIGURE 11 LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION) 55
FIGURE 12 LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT 2024 VS. 2029 (USD MILLION) 56
FIGURE 13 LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION 2024 VS. 2029 (USD MILLION) 56
FIGURE 14 LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2024 VS. 2029 (USD MILLION) 57
FIGURE 15 LIFE SCIENCE ANALYTICS MARKET: GEOGRAPHICAL SNAPSHOT 58
FIGURE 16 RISING TECHNOLOGICAL ADVANCEMENTS AND GROWING ADOPTION OF ANALYTICS SOLUTIONS FOR CLINICAL TRIALS TO DRIVE MARKET 59
FIGURE 17 NORTH AMERICA TO DOMINATE LABORATORY INFORMATICS MARKET
DURING FORECAST PERIOD 60
FIGURE 18 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES IN NORTH AMERICA ACCOUNTED FOR LARGEST MARKET SHARE IN 2023 60
FIGURE 19 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 61
FIGURE 20 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES
DURING FORECAST PERIOD 61
FIGURE 21 LIFE SCIENCE ANALYTICS MARKET: DRIVERS, RESTRAINTS OPPORTUNITIES, AND CHALLENGES 62
FIGURE 22 HEALTH EXPENDITURE AS SHARE OF GDP, 2022 (OR NEAREST YEAR) 63
FIGURE 23 LIFE SCIENCE ANALYTICS MARKET ECOSYSTEM 78
FIGURE 24 LIFE SCIENCE ANALYTICS MARKET: VALUE CHAIN ANALYSIS 79
FIGURE 25 LIFE SCIENCE ANALYTICS MARKET: PORTER’S FIVE FORCES ANALYSIS 81
FIGURE 26 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS 83
FIGURE 27 KEY BUYING CRITERIA FOR END USERS 84
FIGURE 28 REVENUE SHIFT IN LIFE SCIENCE ANALYTICS MARKET 96
FIGURE 29 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR “LIFE SCIENCE ANALYTICS” PATENTS, JANUARY 2011–SEPTEMBER 2024 97
FIGURE 30 MAJOR PATENTS FOR LIFE SCIENCE ANALYTICS
(JANUARY 2011- SEPTEMBER 2024) 98
FIGURE 31 FUNDING OF PLAYERS IN LIFE SCIENCE ANALYTICS MARKET 103
FIGURE 32 MARKET POTENTIAL OF AI/GENERATIVE AI, BY INDUSTRY 107
FIGURE 33 IMPACT OF GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS 110
FIGURE 34 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET SNAPSHOT 177
FIGURE 35 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET SNAPSHOT 227
FIGURE 36 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN
LIFE SCIENCE ANALYTICS MARKET 289
FIGURE 37 REVENUE ANALYSIS OF KEY PLAYERS IN LIFE SCIENCE
ANALYTICS MARKET (2019–2023) 290
FIGURE 38 LIFE SCIENCE ANALYTICS MARKET: MARKET SHARE ANALYSIS (2023) 291
FIGURE 39 LIFE SCIENCE ANALYTICS MARKET: COMPANY EVALUATION MATRIX
(KEY PLAYERS), 2023 294
FIGURE 40 LIFE SCIENCE ANALYTICS MARKET: COMPANY FOOTPRINT (25 COMPANIES) 295
FIGURE 41 LIFE SCIENCE ANALYTICS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023 302
FIGURE 42 EV/EBITDA OF KEY VENDORS 306
FIGURE 43 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF
LIFE SCIENCE ANALYTICS VENDORS 306
FIGURE 44 ORACLE: COMPANY SNAPSHOT (2023) 310
FIGURE 45 ACCENTURE: COMPANY SNAPSHOT (2023) 320
FIGURE 46 IQVIA: COMPANY SNAPSHOT (2023) 324
FIGURE 47 COGNIZANT: COMPANY SNAPSHOT (2023) 330
FIGURE 48 WIPRO: COMPANY SNAPSHOT (2023) 334
FIGURE 49 VERADIGM: COMPANY SNAPSHOT (2023) 338
FIGURE 50 UNITED HEALTH GROUP: COMPANY SNAPSHOT (2023) 340
FIGURE 51 MICROSOFT: COMPANY SNAPSHOT (2023) 343
FIGURE 52 EXLSERVICE HOLDINGS: COMPANY SNAPSHOT (2023) 348
FIGURE 53 CLARIVATE: COMPANY SNAPSHOT (2023) 362
FIGURE 54 SALESFORCE: COMPANY SNAPSHOT (2023) 370

List of Tables

TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 39
TABLE 2 LIFE SCIENCE ANALYTICS MARKET: RISK ASSESSMENT 54
TABLE 3 PHARMACEUTICAL COMPANIES IMPACTED BY CYBERINCIDENTS, 2024 68
TABLE 4 LIFE SCIENCE ANALYTICS MARKET: ROLE IN ECOSYSTEM 78
TABLE 5 LIFE SCIENCE ANALYTICS MARKET: PORTER’S FIVE FORCES 81
TABLE 6 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS (%) 84
TABLE 7 KEY BUYING CRITERIA FOR END USERS 85
TABLE 8 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES AND OTHER ORGANIZATIONS 88
TABLE 9 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES AND OTHER ORGANIZATIONS 88
TABLE 10 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES AND OTHER ORGANIZATIONS 89
TABLE 11 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES AND OTHER ORGANIZATIONS 90
TABLE 12 MIDDLE EAST & AFRICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 90
TABLE 13 AVERAGE SELLING PRICE OF LIFE SCIENCE ANALYTICS SOLUTIONS BY APPLICATION 94
TABLE 14 AVERAGE SELLING PRICE OF ANALYTICS SOLUTIONS, BY REGION 94
TABLE 15 LIFE SCIENCE ANALYTICS MARKET: DETAILED LIST OF CONFERENCES AND EVENTS 95
TABLE 16 LIST OF PATENTS/PATENT APPLICATIONS 98
TABLE 17 UNMET NEEDS IN LIFE SCIENCE ANALYTICS MARKET 100
TABLE 18 END-USER EXPECTATIONS IN LIFE SCIENCE ANALYTICS MARKET 101
TABLE 19 MAJOR INVESTMENTS IN AI IN LIFE SCIENCE ANALYTICS MARKET 104
TABLE 20 LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION) 117
TABLE 21 DESCRIPTIVE ANALYTICS MARKET, BY REGION, 2022–2029 (USD MILLION) 118
TABLE 22 PREDICTIVE ANALYTICS MARKET, BY REGION, 2022–2029 (USD MILLION) 120
TABLE 23 PRESCRIPTIVE ANALYTICS MARKET, BY REGION, 2022–2029 (USD MILLION) 121
TABLE 24 LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2022–2029 (USD MILLION) 123
TABLE 25 LIFE SCIENCE ANALYTICS SERVICES MARKET, BY TYPE 2022–2029 (USD MILLION) 124
TABLE 26 LIFE SCIENCE ANALYTICS SERVICES MARKET, BY REGION 2022–2029 (USD MILLION) 124
TABLE 27 MANAGED SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 125
TABLE 28 MANAGED SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 126
TABLE 29 ANALYTICAL SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 127
TABLE 30 CONSULTING SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 128
TABLE 31 PROFESSIONAL SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 129
TABLE 32 PROFESSIONAL SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 129
TABLE 33 TRAINING & IMPLEMENTATION SERVICES MARKET, BY REGION 2022–2029 (USD MILLION) 130
TABLE 34 MAINTENANCE & SUPPORT SERVICES MARKET, BY REGION 2022–2029 (USD MILLION) 131
TABLE 35 OTHER PROFESSIONAL SERVICES MARKET, BY REGION 2022–2029 (USD MILLION) 132
TABLE 36 LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY TYPE 2022–2029 (USD MILLION) 133
TABLE 37 LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY REGION 2022–2029 (USD MILLION) 134
TABLE 38 ON-PREMISE SOLUTIONS MARKET, BY REGION, 2022–2029 (USD MILLION) 135
TABLE 39 CLOUD-BASED SOLUTIONS MARKET, BY REGION, 2022–2029 (USD MILLION) 136
TABLE 40 SAAS-BASED SOLUTIONS MARKET, BY REGION, 2022–2029 (USD MILLION) 137
TABLE 41 LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 139
TABLE 42 LIFE SCIENCE ANALYTICS MARKET: COMMERCIALLY AVAILABLE R&D SOLUTIONS 140
TABLE 43 LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION) 141
TABLE 44 LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY REGION, 2022–2029 (USD MILLION) 141
TABLE 45 LIFE SCIENCE ANALYTICS MARKET: COMMERCIALLY AVAILABLE
CLINICAL TRIAL SOLUTIONS 142
TABLE 46 LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY REGION 2022–2029 (USD MILLION) 143
TABLE 47 LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY TYPE 2022–2029 (USD MILLION) 143
TABLE 48 LABORATORY SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 144
TABLE 49 PATIENT RECRUITMENT SERVICES MARKET, BY REGION 2022–2029 (USD MILLION) 145
TABLE 50 SITE IDENTIFICATION SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 146
TABLE 51 OTHER CLINICAL TRIAL SERVICES MARKET, BY REGION 2022–2029 (USD MILLION) 147
TABLE 52 LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE 2022–2029 (USD MILLION) 148
TABLE 53 PHASE I CLINICAL TRIAL ANALYTICS MARKET, BY REGION 2022–2029 (USD MILLION) 149
TABLE 54 PHASE II CLINICAL TRIAL ANALYTICS MARKET, BY REGION 2022–2029 (USD MILLION) 150
TABLE 55 PHASE III CLINICAL TRIAL ANALYTICS MARKET, BY REGION 2022–2029 (USD MILLION) 151
TABLE 56 LIFE SCIENCE ANALYTICS MARKET: COMMERCIALLY AVAILABLE
PRECLINICAL SOLUTIONS 152
TABLE 57 LIFE SCIENCE ANALYTICS MARKET FOR PRECLINICAL & DRUG DISCOVERY BY REGION, 2022–2029 (USD MILLION) 153
TABLE 58 LIFE SCIENCE ANALYTICS MARKET FOR COMMERCIAL ANALYTICS, BY TYPE 2022–2029 (USD MILLION) 154
TABLE 59 LIFE SCIENCE ANALYTICS MARKET FOR COMMERCIAL ANALYTICS, BY REGION, 2022–2029 (USD MILLION) 154
TABLE 60 LIFE SCIENCE ANALYTICS MARKET: COMMERCIALLY AVAILABLE SALES & MARKETING SOLUTIONS 155
TABLE 61 LIFE SCIENCE ANALYTICS MARKET FOR SALES & MARKETING SUPPORT BY REGION, 2022–2029 (USD MILLION) 156
TABLE 62 LIFE SCIENCE ANALYTICS MARKET FOR MARKET ACCESS, BY REGION 2022–2029 (USD MILLION) 157
TABLE 63 LIFE SCIENCE ANALYTICS MARKET FOR RWE & VALUE EVIDENCE, BY REGION, 2022–2029 (USD MILLION) 158
TABLE 64 LIFE SCIENCE ANALYTICS MARKET FOR ENGAGEMENT SERVICES, BY REGION, 2022–2029 (USD MILLION) 159
TABLE 65 LIFE SCIENCE ANALYTICS MARKET: COMMERCIALLY AVAILABLE REGULATORY COMPLIANCE SOLUTIONS 160
TABLE 66 LIFE SCIENCE ANALYTICS MARKET FOR REGULATORY COMPLIANCE, BY REGION, 2022–2029 (USD MILLION) 161
TABLE 67 LIFE SCIENCE ANALYTICS MARKET: COMMERCIALLY AVAILABLE SUPPLY CHAIN OPTIMIZATION SOLUTIONS 162
TABLE 68 LIFE SCIENCE ANALYTICS MARKET FOR MANUFACTURING & SUPPLY CHAIN OPTIMIZATION, BY REGION, 2022–2029 (USD MILLION) 162
TABLE 69 LIFE SCIENCE ANALYTICS MARKET FOR SAFETY, BY TYPE 2022–2029 (USD MILLION) 163
TABLE 70 LIFE SCIENCE ANALYTICS MARKET FOR SAFETY, BY REGION 2022–2029 (USD MILLION) 163
TABLE 71 LIFE SCIENCE ANALYTICS MARKET: COMMERCIALLY AVAILABLE PHARMACOVIGILANCE SOLUTIONS 164
TABLE 72 LIFE SCIENCE ANALYTICS MARKET FOR PHARMACOVIGILANCE, BY REGION 2022–2029 (USD MILLION) 165
TABLE 73 LIFE SCIENCE ANALYTICS MARKET FOR MEDICAL DEVICE SAFETY, BY REGION, 2022–2029 (USD MILLION) 166
TABLE 74 LIFE SCIENCE ANALYTICS MARKET FOR DIAGNOSTIC VIGILANCE, BY REGION, 2022–2029 (USD MILLION) 167
TABLE 75 LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2022–2029 (USD MILLION) 169
TABLE 76 LIFE SCIENCE ANALYTICS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION) 170
TABLE 77 LIFE SCIENCE ANALYTICS MARKET FOR MEDICAL DEVICE COMPANIES, BY REGION, 2022–2029 (USD MILLION) 171
TABLE 78 LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH CENTERS, BY REGION 2022–2029 (USD MILLION) 172
TABLE 79 LIFE SCIENCE ANALYTICS MARKET FOR OUTSOURCED LIFE SCIENCE ORGANIZATIONS, BY REGION, 2022–2029 (USD MILLION) 173
TABLE 80 LIFE SCIENCE ANALYTICS MARKET, BY REGION, 2022–2029 (USD MILLION) 175
TABLE 81 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 177
TABLE 82 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY TYPE 2022–2029 (USD MILLION) 178
TABLE 83 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT 2022–2029 (USD MILLION) 178
TABLE 84 NORTH AMERICA: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY TYPE 2022–2029 (USD MILLION) 178
TABLE 85 NORTH AMERICA: MANAGED SERVICES MARKET, BY TYPE 2022–2029 (USD MILLION) 179
TABLE 86 NORTH AMERICA: PROFESSIONAL SERVICES MARKET, BY TYPE 2022–2029 (USD MILLION) 179
TABLE 87 NORTH AMERICA: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY TYPE 2022–2029 (USD MILLION) 179
TABLE 88 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION 2022–2029 (USD MILLION) 180
TABLE 89 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION) 180
TABLE 90 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS BY TYPE, 2022–2029 (USD MILLION) 180
TABLE 91 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS BY PHASE, 2022–2029 (USD MILLION) 181
TABLE 92 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR COMMERCIAL ANALYTICS, BY TYPE, 2022–2029 (USD MILLION) 181
TABLE 93 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR SAFETY, BY TYPE 2022–2029 (USD MILLION) 181
TABLE 94 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY END USER 2022–2029 (USD MILLION) 182
TABLE 95 US: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION) 183
TABLE 96 US: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT 2022–2029 (USD MILLION) 183
TABLE 97 US: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY TYPE 2022–2029 (USD MILLION) 183
TABLE 98 US: MANAGED SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 183
TABLE 99 US: PROFESSIONAL SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 184
TABLE 100 US: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY TYPE 2022–2029 (USD MILLION) 184
TABLE 101 US: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION 2022–2029 (USD MILLION) 184
TABLE 102 US: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION) 185
TABLE 103 US: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY TYPE 2022–2029 (USD MILLION) 185
TABLE 104 US: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE 2022–2029 (USD MILLION) 185
TABLE 105 US: LIFE SCIENCE ANALYTICS MARKET FOR COMMERCIAL ANALYTICS, BY TYPE, 2022–2029 (USD MILLION) 186
TABLE 106 US: LIFE SCIENCE ANALYTICS MARKET FOR SAFETY, BY TYPE 2022–2029 (USD MILLION) 186
TABLE 107 US: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2022–2029 (USD MILLION) 186
TABLE 108 CANADA: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION) 187
TABLE 109 CANADA: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT 2022–2029 (USD MILLION) 188
TABLE 110 CANADA: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY TYPE 2022–2029 (USD MILLION) 188
TABLE 111 CANADA: MANAGED SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 188
TABLE 112 CANADA: PROFESSIONAL SERVICES MARKET, BY TYPE 2022–2029 (USD MILLION) 189
TABLE 113 CANADA: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY TYPE 2022–2029 (USD MILLION) 189
TABLE 114 CANADA: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION 2022–2029 (USD MILLION) 189
TABLE 115 CANADA: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT BY TYPE, 2022–2029 (USD MILLION) 190
TABLE 116 CANADA: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY TYPE, 2022–2029 (USD MILLION) 190
TABLE 117 CANADA: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2022–2029 (USD MILLION) 190
TABLE 118 CANADA: LIFE SCIENCE ANALYTICS MARKET FOR COMMERCIAL ANALYTICS BY TYPE, 2022–2029 (USD MILLION) 191
TABLE 119 CANADA: LIFE SCIENCE ANALYTICS MARKET FOR SAFETY, BY TYPE 2022–2029 (USD MILLION) 191
TABLE 120 CANADA: LIFE SCIENCE ANALYTICS MARKET, BY END USER 2022–2029 (USD MILLION) 191
TABLE 121 EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 193
TABLE 122 EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION) 193
TABLE 123 EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT 2022–2029 (USD MILLION) 193
TABLE 124 EUROPE: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY TYPE 2022–2029 (USD MILLION) 194
TABLE 125 EUROPE: MANAGED SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 194
TABLE 126 EUROPE: PROFESSIONAL SERVICES MARKET, BY TYPE 2022–2029 (USD MILLION) 194
TABLE 127 EUROPE: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY TYPE 2022–2029 (USD MILLION) 195
TABLE 128 EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION 2022–2029 (USD MILLION) 195
TABLE 129 EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT BY TYPE, 2022–2029 (USD MILLION) 195
TABLE 130 EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY TYPE, 2022–2029 (USD MILLION) 196
TABLE 131 EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2022–2029 (USD MILLION) 196
TABLE 132 EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR COMMERCIAL ANALYTICS BY TYPE, 2022–2029 (USD MILLION) 196
TABLE 133 EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR SAFETY, BY TYPE 2022–2029 (USD MILLION) 197
TABLE 134 EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY END USER 2022–2029 (USD MILLION) 197
TABLE 135 GERMANY: LIFE SCIENCE ANALYTICS MARKET, BY TYPE 2022–2029 (USD MILLION) 198
TABLE 136 GERMANY: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT 2022–2029 (USD MILLION) 198
TABLE 137 GERMANY: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY TYPE 2022–2029 (USD MILLION) 199
TABLE 138 GERMANY: MANAGED SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 199
TABLE 139 GERMANY: PROFESSIONAL SERVICES MARKET, BY TYPE 2022–2029 (USD MILLION) 199
TABLE 140 GERMANY: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY TYPE 2022–2029 (USD MILLION) 200
TABLE 141 GERMANY: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION 2022–2029 (USD MILLION) 200
TABLE 142 GERMANY: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION) 200
TABLE 143 GERMANY: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY TYPE, 2022–2029 (USD MILLION) 201
TABLE 144 GERMANY: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2022–2029 (USD MILLION) 201
TABLE 145 GERMANY: LIFE SCIENCE ANALYTICS MARKET FOR COMMERCIAL ANALYTICS BY TYPE, 2022–2029 (USD MILLION) 201
TABLE 146 GERMANY: LIFE SCIENCE ANALYTICS MARKET FOR SAFETY, BY TYPE 2022–2029 (USD MILLION) 202
TABLE 147 GERMANY: LIFE SCIENCE ANALYTICS MARKET, BY END USER 2022–2029 (USD MILLION) 202
TABLE 148 FRANCE: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION) 203
TABLE 149 FRANCE: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT 2022–2029 (USD MILLION) 203
TABLE 150 FRANCE: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY TYPE 2022–2029 (USD MILLION) 203
TABLE 151 FRANCE: MANAGED SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 204
TABLE 152 FRANCE: PROFESSIONAL SERVICES MARKET, BY TYPE 2022–2029 (USD MILLION) 204
TABLE 153 FRANCE: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY TYPE 2022–2029 (USD MILLION) 204
TABLE 154 FRANCE: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION 2022–2029 (USD MILLION) 205
TABLE 155 FRANCE: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT BY TYPE, 2022–2029 (USD MILLION) 205
TABLE 156 FRANCE: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY TYPE, 2022–2029 (USD MILLION) 205
TABLE 157 FRANCE: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2022–2029 (USD MILLION) 206
TABLE 158 FRANCE: LIFE SCIENCE ANALYTICS MARKET FOR COMMERCIAL ANALYTICS BY TYPE, 2022–2029 (USD MILLION) 206
TABLE 159 FRANCE: LIFE SCIENCE ANALYTICS MARKET FOR SAFETY, BY TYPE 2022–2029 (USD MILLION) 206
TABLE 160 FRANCE: LIFE SCIENCE ANALYTICS MARKET, BY END USER 2022–2029 (USD MILLION) 207
TABLE 161 UK: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION) 208
TABLE 162 UK: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT 2022–2029 (USD MILLION) 208
TABLE 163 UK: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY TYPE 2022–2029 (USD MILLION) 208
TABLE 164 UK: MANAGED SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 208
TABLE 165 UK: PROFESSIONAL SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 209
TABLE 166 UK: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY TYPE 2022–2029 (USD MILLION) 209
TABLE 167 UK: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION 2022–2029 (USD MILLION) 209
TABLE 168 UK: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION) 210
TABLE 169 UK: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY TYPE 2022–2029 (USD MILLION) 210
TABLE 170 UK: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE 2022–2029 (USD MILLION) 210
TABLE 171 UK: LIFE SCIENCE ANALYTICS MARKET FOR COMMERCIAL ANALYTICS, BY TYPE, 2022–2029 (USD MILLION) 211
TABLE 172 UK: LIFE SCIENCE ANALYTICS MARKET FOR SAFETY, BY TYPE 2022–2029 (USD MILLION) 211
TABLE 173 UK: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2022–2029 (USD MILLION) 211
TABLE 174 ITALY: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION) 212
TABLE 175 ITALY: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT 2022–2029 (USD MILLION) 212
TABLE 176 ITALY: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY TYPE 2022–2029 (USD MILLION) 213
TABLE 177 ITALY: MANAGED SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 213
TABLE 178 ITALY: PROFESSIONAL SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 213
TABLE 179 ITALY: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY TYPE 2022–2029 (USD MILLION) 214
TABLE 180 ITALY: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION 2022–2029 (USD MILLION) 214
TABLE 181 ITALY: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT BY TYPE, 2022–2029 (USD MILLION) 214
TABLE 182 ITALY: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY TYPE 2022–2029 (USD MILLION) 215
TABLE 183 ITALY: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE 2022–2029 (USD MILLION) 215
TABLE 184 ITALY: LIFE SCIENCE ANALYTICS MARKET FOR COMMERCIAL ANALYTICS, BY TYPE, 2022–2029 (USD MILLION) 215
TABLE 185 ITALY: LIFE SCIENCE ANALYTICS MARKET FOR SAFETY, BY TYPE 2022–2029 (USD MILLION) 216
TABLE 186 ITALY: LIFE SCIENCE ANALYTICS MARKET, BY END USER 2022–2029 (USD MILLION) 216
TABLE 187 SPAIN: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION) 217
TABLE 188 SPAIN: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT 2022–2029 (USD MILLION) 217
TABLE 189 SPAIN: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY TYPE 2022–2029 (USD MILLION) 217
TABLE 190 SPAIN: MANAGED SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 217
TABLE 191 SPAIN: PROFESSIONAL SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 218
TABLE 192 SPAIN: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY TYPE 2022–2029 (USD MILLION) 218
TABLE 193 SPAIN: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION 2022–2029 (USD MILLION) 218
TABLE 194 SPAIN: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT BY TYPE, 2022–2029 (USD MILLION) 219
TABLE 195 SPAIN: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY TYPE 2022–2029 (USD MILLION) 219
TABLE 196 SPAIN: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE 2022–2029 (USD MILLION) 219
TABLE 197 SPAIN: LIFE SCIENCE ANALYTICS MARKET FOR COMMERCIAL ANALYTICS, BY TYPE, 2022–2029 (USD MILLION) 220
TABLE 198 SPAIN: LIFE SCIENCE ANALYTICS MARKET FOR SAFETY, BY TYPE 2022–2029 (USD MILLION) 220
TABLE 199 SPAIN: LIFE SCIENCE ANALYTICS MARKET, BY END USER 2022–2029 (USD MILLION) 220
TABLE 200 REST OF EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY TYPE 2022–2029 (USD MILLION) 221
TABLE 201 REST OF EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT 2022–2029 (USD MILLION) 221
TABLE 202 REST OF EUROPE: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY TYPE 2022–2029 (USD MILLION) 222
TABLE 203 REST OF EUROPE: MANAGED SERVICES MARKET, BY TYPE 2022–2029 (USD MILLION) 222
TABLE 204 REST OF EUROPE: PROFESSIONAL SERVICES MARKET, BY TYPE 2022–2029 (USD MILLION) 222
TABLE 205 REST OF EUROPE: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY TYPE 2022–2029 (USD MILLION) 223
TABLE 206 REST OF EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION 2022–2029 (USD MILLION) 223
TABLE 207 REST OF EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION) 223
TABLE 208 REST OF EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS BY TYPE, 2022–2029 (USD MILLION) 224
TABLE 209 REST OF EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS BY PHASE, 2022–2029 (USD MILLION) 224
TABLE 210 REST OF EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR COMMERCIAL ANALYTICS, BY TYPE, 2022–2029 (USD MILLION) 224
TABLE 211 REST OF EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR SAFETY, BY TYPE, 2022–2029 (USD MILLION) 225
TABLE 212 REST OF EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY END USER 2022–2029 (USD MILLION) 225
TABLE 213 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 228
TABLE 214 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY TYPE 2022–2029 (USD MILLION) 228
TABLE 215 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT 2022–2029 (USD MILLION) 228
TABLE 216 ASIA PACIFIC: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY TYPE 2022–2029 (USD MILLION) 229
TABLE 217 ASIA PACIFIC: MANAGED SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 229
TABLE 218 ASIA PACIFIC: PROFESSIONAL SERVICES MARKET, BY TYPE 2022–2029 (USD MILLION) 229
TABLE 219 ASIA PACIFIC: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY TYPE 2022–2029 (USD MILLION) 230
TABLE 220 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION 2022–2029 (USD MILLION) 230
TABLE 221 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION) 230
TABLE 222 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY TYPE, 2022–2029 (USD MILLION) 231
TABLE 223 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2022–2029 (USD MILLION) 231
TABLE 224 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET FOR COMMERCIAL ANALYTICS BY TYPE, 2022–2029 (USD MILLION) 231
TABLE 225 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET FOR SAFETY, BY TYPE 2022–2029 (USD MILLION) 232
TABLE 226 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY END USER 2022–2029 (USD MILLION) 232
TABLE 227 JAPAN: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION) 233
TABLE 228 JAPAN: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT 2022–2029 (USD MILLION) 233
TABLE 229 JAPAN: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY TYPE 2022–2029 (USD MILLION) 234
TABLE 230 JAPAN: MANAGED SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 234
TABLE 231 JAPAN: PROFESSIONAL SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 234
TABLE 232 JAPAN: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY TYPE 2022–2029 (USD MILLION) 235
TABLE 233 JAPAN: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION 2022–2029 (USD MILLION) 235
TABLE 234 JAPAN: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT BY TYPE, 2022–2029 (USD MILLION) 235
TABLE 235 JAPAN: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY TYPE 2022–2029 (USD MILLION) 236
TABLE 236 JAPAN: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2022–2029 (USD MILLION) 236
TABLE 237 JAPAN: LIFE SCIENCE ANALYTICS MARKET FOR COMMERCIAL ANALYTICS, BY TYPE, 2022–2029 (USD MILLION) 236
TABLE 238 JAPAN: LIFE SCIENCE ANALYTICS MARKET FOR SAFETY, BY TYPE 2022–2029 (USD MILLION) 237
TABLE 239 JAPAN: LIFE SCIENCE ANALYTICS MARKET, BY END USER 2022–2029 (USD MILLION) 237
TABLE 240 CHINA: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION) 238
TABLE 241 CHINA: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT 2022–2029 (USD MILLION) 238
TABLE 242 CHINA: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY TYPE 2022–2029 (USD MILLION) 238
TABLE 243 CHINA: MANAGED SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 239
TABLE 244 CHINA: PROFESSIONAL SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 239
TABLE 245 CHINA: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY TYPE 2022–2029 (USD MILLION) 239
TABLE 246 CHINA: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION 2022–2029 (USD MILLION) 240
TABLE 247 CHINA: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT BY TYPE, 2022–2029 (USD MILLION) 240
TABLE 248 CHINA: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY TYPE 2022–2029 (USD MILLION) 240
TABLE 249 CHINA: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2022–2029 (USD MILLION) 241
TABLE 250 CHINA: LIFE SCIENCE ANALYTICS MARKET FOR COMMERCIAL ANALYTICS, BY TYPE, 2022–2029 (USD MILLION) 241
TABLE 251 CHINA: LIFE SCIENCE ANALYTICS MARKET FOR SAFETY, BY TYPE 2022–2029 (USD MILLION) 241
TABLE 252 CHINA: LIFE SCIENCE ANALYTICS MARKET, BY END USER 2022–2029 (USD MILLION) 242
TABLE 253 INDIA: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2022–2029 (USD MILLION) 243
TABLE 254 INDIA: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT 2022–2029 (USD MILLION) 243
TABLE 255 INDIA: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY TYPE 2022–2029 (USD MILLION) 243
TABLE 256 INDIA: MANAGED SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 243
TABLE 257 INDIA: PROFESSIONAL SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 244
TABLE 258 INDIA: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY TYPE 2022–2029 (USD MILLION) 244
TABLE 259 INDIA: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION 2022–2029 (USD MILLION) 244
TABLE 260 INDIA: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT BY TYPE, 2022–2029 (USD MILLION) 245
TABLE 261 INDIA: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY TYPE 2022–2029 (USD MILLION) 245
TABLE 262 INDIA: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE 2022–2029 (USD MILLION) 245
TABLE 263 INDIA: LIFE SCIENCE ANALYTICS MARKET FOR COMMERCIAL ANALYTICS, BY TYPE, 2022–2029 (USD MILLION) 246
TABLE 264 INDIA: LIFE SCIENCE ANALYTICS MARKET FOR SAFETY, BY TYPE 2022–2029 (USD MILLION) 246
TABLE 265 INDIA: LIFE SCIENCE ANALYTICS MARKET, BY END USER 2022–2029 (USD MILLION) 246
TABLE 266 REST OF ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY TYPE 2022–2029 (USD MILLION) 247
TABLE 267 REST OF ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2022–2029 (USD MILLION) 248
TABLE 268 REST OF ASIA PACIFIC: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 248
TABLE 269 REST OF ASIA PACIFIC: MANAGED SERVICES MARKET, BY TYPE 2022–2029 (USD MILLION) 248
TABLE 270 REST OF ASIA PACIFIC: PROFESSIONAL SERVICES MARKET, BY TYPE 2022–2029 (USD MILLION) 249
TABLE 271 REST OF ASIA PACIFIC: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022–2029 (USD MILLION) 249
TABLE 272 REST OF ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 249
TABLE 273 REST OF ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION) 250
TABLE 274 REST OF ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY TYPE, 2022–2029 (USD MILLION) 250
TABLE 275 REST OF ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2022–2029 (USD MILLION) 250
TABLE 276 REST OF ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET FOR COMMERCIAL ANALYTICS, BY TYPE, 2022–2029 (USD MILLION) 251
TABLE 277 REST OF ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET FOR SAFETY, BY TYPE, 2022–2029 (USD MILLION) 251
TABLE 278 REST OF ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY END USER 2022–2029 (USD MILLION) 251
TABLE 279 LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY COUNTRY 2022–2029 (USD MILLION) 253
TABLE 280 L